Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Diabetologie is Scopus-indexed (Q4, CiteScore 0.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Medizin.
Checked against the index lists dated .
ISSN 2731-7447Verify ISSN ↗2731-7455Verify ISSN ↗
Publisher: Springer Medizin
Cost to publish: About US$3,390 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 239 / 250 | 4th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q4, CiteScore 0.2.
Diabetologie is Q4 in Endocrinology, Diabetes and Metabolism (rank 239 of 250), by CiteScore 2025.
Diabetologie is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.2, which places it in quartile Q4 at the 4th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.110, quartile Q4, with an H-index of 12.
The publisher lists an article processing charge of about US$3,390 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Diabetologie is published by Springer Medizin. Its print ISSN is 2731-7447 and its online ISSN is 2731-7455.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Diabetologie has an h-index of 5 and a 2-year mean of 0.2 citations per paper (OpenAlex). Its Scopus CiteScore is 0.2, quartile Q4. On 2-year citations it ranks #219 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Diabetologie published 133 papers in 2025; its busiest recent year was 2024 with 144. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 85 research articles (2025–2026), authors are most often from Germany (83.3%), Switzerland (8%) and Austria (4.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.